Balanced news tone
News Sentiment
ABVC sentiment intelligence
ABVC Biopharma Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
77/100 classification confidence.
directly relevant articles
high-authority source matches
-16.1% over one week, +26.9% over four weeks, trend inactive, and near fair-value range.
ABVC BioPharma (ABVC) replaces auditor and reiterates going-concern language
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 14 May 2026 07:00
- Source
- Market source
TradingKey
The article provides a market overview for ABVC Biopharma Inc. (ABVC), showing its stock price, market capitalization, and a prompt for user comments. It also highlights the platform's features like financial data, analysis tools, and various market categories presented by Tradin
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 11 May 2026 23:40
- Source
- TradingKey
Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results
- Tone
- Positive 66/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- simplywall.st
Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 11 May 2026 07:00
- Source
- Market source
Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 25 Apr 2026 07:00
- Source
- Market source
Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 21 Apr 2026 07:00
- Source
- Market source
ABVC Options Chain — NASDAQ:ABVC
This page provides an options chain for ABVC BioPharma, Inc. (NASDAQ:ABVC), allowing users to track market movements and assess risks for call and put options. It displays live pricing, Greeks, implied volatility, and other key metrics for various expiration dates and strike pric
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Apr 2026 13:40
- Source
- TradingView — Track All Markets
ABVC Options Volatility — NASDAQ:ABVC
This article from TradingView provides an overview of ABVC BioPharma, Inc.'s options volatility. It focuses on implied volatility curves and at-the-money implied volatility across different expiration dates to help traders assess risks and craft options strategies based on market
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 12 Apr 2026 13:40
- Source
- TradingView — Track All Markets
12 Health Care Stocks Moving In Monday's Intraday Session - ABVC BioPharma (NASDAQ:ABVC), Aditxt (NASDAQ
This article lists 12 health care stocks that experienced significant movement during Monday's intraday trading session. It highlights both gainers, such as Profusa (NASDAQ:PFSA) and IO Biotech (NASDAQ:IOBT), and losers, including Akari Therapeutics (NASDAQ:AKTX) and Viridian The
- Tone
- Positive 64/100
- Event
- Market update
- Published
- 06 Apr 2026 17:11
- Source
- Benzinga
ABVC Stock News Today | Earnings, Events & Price Alerts
This article provides recent news and event updates for ABVC BioPharma, Inc. (ABVC), focusing on its financial activities, licensing agreements, and progress in clinical trials. Key events include securing licensing payments for oncology and psychiatric disorder products, signifi
- Tone
- Positive 76/100
- Event
- Earnings
- Published
- 01 Apr 2026 10:09
- Source
- Intellectia AI
A Look Back at Biotechnology Stocks’ Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 29 Mar 2026 07:00
- Source
- TradingView
BioLite, Inc., an ABVC BioPharma Subsidiary, Receives $230,000 Milestone Payment from AiBtl, Advancing Botanical Drug Licensing Collaboration
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 26 Aug 2025 07:00
- Source
- Market source
ABVC BioPharma Converts Strategic Note Into Equity in AiBtl BioPharma; Commits to Up to $20 Million in Total Investment
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Jun 2025 07:00
- Source
- Market source
Quantum BioPharma (QNTM) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Apr 2025 23:27
- Source
- Stock Titan
ABVC BioPharma (ABVC) Stock Forecast and Price Target 2026
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 11 May 2024 15:01
- Source
- MarketBeat
AiBtl BioPharma Inc. Acquired TT Life Company, Valued at $8.33M, With 1.66M AiBtl Shares at $5 per Share
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Apr 2024 07:00
- Source
- Market source
What is the current Price Target and Forecast for ABVC BIOPHARMA (ABVC)
- Tone
- Neutral 50/100
- Event
- Guidance
- Published
- 11 Nov 2022 18:11
- Source
- Zacks Investment Research
ABVC BioPharma (ABVC) Stock Price, News & Analysis
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 Sep 2021 21:04
- Source
- MarketBeat
Abvc Biopharma Stock Price Forecast. Should You Buy ABVC?
- Tone
- Positive 66/100
- Event
- Guidance
- Published
- 12 Aug 2021 16:46
- Source
- StockInvest.us
ABVC Stock Price and Chart — NASDAQ:ABVC
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 04 Aug 2021 10:05
- Source
- TradingView